The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
At a time when pharmaceutical companies face increasing price pressures around the globe from key payers, including public and government insurance systems, reducing operational expenses is a major driver of outsourcing pharmaceutical manufacturing to CDMOs. Also, an increasing number of pharmaceutical companies are refocusing on their core capabilities and strengths, leading to divestments of in-house manufacturing capacities in some areas and to a gro
The global CMO & CDMO market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for CMO & CDMO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for CMO & CDMO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for CMO & CDMO in Pharmaceutical Industry is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of CMO & CDMO include Recipharm, AMRI3, Patheon, Aenova, Catalent, Amatsigroup, WuXi PharmaTech, Strides Shasun and Piramal, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for CMO & CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CMO & CDMO.
Report Scope
The CMO & CDMO market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CMO & CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CMO & CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Recipharm
AMRI3
Patheon
Aenova
Catalent
Amatsigroup
WuXi PharmaTech
Strides Shasun
Piramal
Siegfried
Segment by Type
Development
API production
Formulation
Segment by Application
Pharmaceutical Industry
Biotechnology
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CMO & CDMO companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
At a time when pharmaceutical companies face increasing price pressures around the globe from key payers, including public and government insurance systems, reducing operational expenses is a major driver of outsourcing pharmaceutical manufacturing to CDMOs. Also, an increasing number of pharmaceutical companies are refocusing on their core capabilities and strengths, leading to divestments of in-house manufacturing capacities in some areas and to a gro
The global CMO & CDMO market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for CMO & CDMO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for CMO & CDMO is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for CMO & CDMO in Pharmaceutical Industry is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of CMO & CDMO include Recipharm, AMRI3, Patheon, Aenova, Catalent, Amatsigroup, WuXi PharmaTech, Strides Shasun and Piramal, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for CMO & CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CMO & CDMO.
Report Scope
The CMO & CDMO market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CMO & CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CMO & CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Recipharm
AMRI3
Patheon
Aenova
Catalent
Amatsigroup
WuXi PharmaTech
Strides Shasun
Piramal
Siegfried
Segment by Type
Development
API production
Formulation
Segment by Application
Pharmaceutical Industry
Biotechnology
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CMO & CDMO companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CMO & CDMO Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Development
1.2.3 API production
1.2.4 Formulation
1.3 Market by Application
1.3.1 Global CMO & CDMO Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Industry
1.3.3 Biotechnology
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global CMO & CDMO Market Perspective (2019-2030)
2.2 CMO & CDMO Growth Trends by Region
2.2.1 Global CMO & CDMO Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 CMO & CDMO Historic Market Size by Region (2019-2024)
2.2.3 CMO & CDMO Forecasted Market Size by Region (2025-2030)
2.3 CMO & CDMO Market Dynamics
2.3.1 CMO & CDMO Industry Trends
2.3.2 CMO & CDMO Market Drivers
2.3.3 CMO & CDMO Market Challenges
2.3.4 CMO & CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CMO & CDMO Players by Revenue
3.1.1 Global Top CMO & CDMO Players by Revenue (2019-2024)
3.1.2 Global CMO & CDMO Revenue Market Share by Players (2019-2024)
3.2 Global CMO & CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by CMO & CDMO Revenue
3.4 Global CMO & CDMO Market Concentration Ratio
3.4.1 Global CMO & CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CMO & CDMO Revenue in 2023
3.5 CMO & CDMO Key Players Head office and Area Served
3.6 Key Players CMO & CDMO Product Solution and Service
3.7 Date of Enter into CMO & CDMO Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CMO & CDMO Breakdown Data by Type
4.1 Global CMO & CDMO Historic Market Size by Type (2019-2024)
4.2 Global CMO & CDMO Forecasted Market Size by Type (2025-2030)
5 CMO & CDMO Breakdown Data by Application
5.1 Global CMO & CDMO Historic Market Size by Application (2019-2024)
5.2 Global CMO & CDMO Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America CMO & CDMO Market Size (2019-2030)
6.2 North America CMO & CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America CMO & CDMO Market Size by Country (2019-2024)
6.4 North America CMO & CDMO Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CMO & CDMO Market Size (2019-2030)
7.2 Europe CMO & CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe CMO & CDMO Market Size by Country (2019-2024)
7.4 Europe CMO & CDMO Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CMO & CDMO Market Size (2019-2030)
8.2 Asia-Pacific CMO & CDMO Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific CMO & CDMO Market Size by Region (2019-2024)
8.4 Asia-Pacific CMO & CDMO Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CMO & CDMO Market Size (2019-2030)
9.2 Latin America CMO & CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America CMO & CDMO Market Size by Country (2019-2024)
9.4 Latin America CMO & CDMO Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CMO & CDMO Market Size (2019-2030)
10.2 Middle East & Africa CMO & CDMO Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa CMO & CDMO Market Size by Country (2019-2024)
10.4 Middle East & Africa CMO & CDMO Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Recipharm
11.1.1 Recipharm Company Detail
11.1.2 Recipharm Business Overview
11.1.3 Recipharm CMO & CDMO Introduction
11.1.4 Recipharm Revenue in CMO & CDMO Business (2019-2024)
11.1.5 Recipharm Recent Development
11.2 AMRI3
11.2.1 AMRI3 Company Detail
11.2.2 AMRI3 Business Overview
11.2.3 AMRI3 CMO & CDMO Introduction
11.2.4 AMRI3 Revenue in CMO & CDMO Business (2019-2024)
11.2.5 AMRI3 Recent Development
11.3 Patheon
11.3.1 Patheon Company Detail
11.3.2 Patheon Business Overview
11.3.3 Patheon CMO & CDMO Introduction
11.3.4 Patheon Revenue in CMO & CDMO Business (2019-2024)
11.3.5 Patheon Recent Development
11.4 Aenova
11.4.1 Aenova Company Detail
11.4.2 Aenova Business Overview
11.4.3 Aenova CMO & CDMO Introduction
11.4.4 Aenova Revenue in CMO & CDMO Business (2019-2024)
11.4.5 Aenova Recent Development
11.5 Catalent
11.5.1 Catalent Company Detail
11.5.2 Catalent Business Overview
11.5.3 Catalent CMO & CDMO Introduction
11.5.4 Catalent Revenue in CMO & CDMO Business (2019-2024)
11.5.5 Catalent Recent Development
11.6 Amatsigroup
11.6.1 Amatsigroup Company Detail
11.6.2 Amatsigroup Business Overview
11.6.3 Amatsigroup CMO & CDMO Introduction
11.6.4 Amatsigroup Revenue in CMO & CDMO Business (2019-2024)
11.6.5 Amatsigroup Recent Development
11.7 WuXi PharmaTech
11.7.1 WuXi PharmaTech Company Detail
11.7.2 WuXi PharmaTech Business Overview
11.7.3 WuXi PharmaTech CMO & CDMO Introduction
11.7.4 WuXi PharmaTech Revenue in CMO & CDMO Business (2019-2024)
11.7.5 WuXi PharmaTech Recent Development
11.8 Strides Shasun
11.8.1 Strides Shasun Company Detail
11.8.2 Strides Shasun Business Overview
11.8.3 Strides Shasun CMO & CDMO Introduction
11.8.4 Strides Shasun Revenue in CMO & CDMO Business (2019-2024)
11.8.5 Strides Shasun Recent Development
11.9 Piramal
11.9.1 Piramal Company Detail
11.9.2 Piramal Business Overview
11.9.3 Piramal CMO & CDMO Introduction
11.9.4 Piramal Revenue in CMO & CDMO Business (2019-2024)
11.9.5 Piramal Recent Development
11.10 Siegfried
11.10.1 Siegfried Company Detail
11.10.2 Siegfried Business Overview
11.10.3 Siegfried CMO & CDMO Introduction
11.10.4 Siegfried Revenue in CMO & CDMO Business (2019-2024)
11.10.5 Siegfried Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
